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Summary
Hemochromatosis, the inherited disorder of iron metab-
olism, leads, if untreated, to progressive iron overload
and premature death. The hemochromatosis gene, HFE,
recently has been identified, and characterization of this
gene has shown that it contains twomutations that result
in amino acid substitutions—cDNA nucleotides 845
GrA (C282Y) and 187 CrG (H63D). Although he-
mochromatosis is common in Caucasians, affectingx1/
300 individuals of northern European origin, it has not
been recognized in other populations. The present study
used PCR and restriction-enzyme digestion to analyze
the frequency of the 845 GrA and 187 CrG mutations
in HLA-typed samples from non-Caucasian populations,
comprising Australian Aboriginal, Chinese, and Pacific
Islanders. Results showed that the 845 GrA mutation
was present in these populations (allele frequency
0.32%), and, furthermore, it was always seen in con-
junction with HLA haplotypes common in Caucasians,
suggesting that 845 GrAmay have been introduced into
these populations by Caucasian admixture. 187 CrG
was present at an allele frequency of 2.68% in the two
populations analyzed (Australian Aboriginal and Chi-
nese). In the Australian Aboriginal samples, 187 CrG
was found to be associated with HLA haplotypes com-
mon in Caucasians, suggesting that it was introduced by
recent admixture. In the Chinese samples analyzed, 187
CrG was present in association with a wide variety of
HLA haplotypes, showing this mutation to be wide-
spread and likely to predate the more genetically re-
stricted 845 GrA mutation.
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Introduction
Hereditary hemochromatosis (MIM 235200), an auto-
somal recessive disorder of iron metabolism, leads to
inappropriately high iron absorption. If hemochroma-
tosis is left undiagnosed and untreated, the excess iron
is stored in the parenchymal cells of major organs, pri-
marily the liver, pancreas, heart, pituitary, and joints,
eventually leading to severe tissue damage and prema-
ture death (Powell et al. 1994).
The hemochromatosis gene, HFE (GenBank accession
number U60319), is located ∼5 Mb distal of HLA-A
and shows significant similarity to major histocompat-
ibility class I genes (Feder et al. 1996). Two single-nu-
cleotide changes have been described in HFE; a GrA
transition at nucleotide 845 of the open reading frame,
resulting in an amino acid substitution of cysteine by
tyrosine (845 GrA; C282Y) and a CrG transition at
nucleotide 187 resulting in a substitution of histidine by
aspartic acid (187CrG; H63D).
Functional studies have shown that 845 GrA disrupts
the interaction of HFE with b2-microglobulin, resulting
in intracellular sequestration of HFE, since the formation
of a heterodimer between HFE and b2-microglobulin is
required for the correct cell-surface presentation of HFE
(Feder et al. 1997). In contrast, 187 CrG does not dis-
rupt binding of HFE with b2-microglobulin, and the ma-
ture molecule is expressed on the cell surface; however,
187 CrG may disrupt binding of HFE to as yet uni-
dentified ligands (Feder et al. 1997).
Some 80%–100% of hemochromatosis patients are
homozygous for 845 GrA (Beutler et al. 1996; Callan-
dro et al. 1996; Feder et al. 1996; Jazwinska et al. 1996;
Jouanolle et al. 1996), providing strong evidence that
845 GrA in HFE is the primary causative mutation in
hemochromatosis. 187 CrG has also been shown to be
involved in hemochromatosis, with some homozygotes
and compound heterozygotes—that is, subjects who
carry both 845 GrA and 187 CrG—showing clinical
expression (Beutler 1997a, 1997b;Martinez et al. 1997;
Risch 1997; Sham et al. 1997).
Hemochromatosis is well recognized as a common
disorder in populations of northern European origin,
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Table 1
Results of 845 GrA Analyses
POPULATION
NO. OF CHROMOSOMES
Total 845G 845A
Australian Aboriginal:
Cape York ( )n  93 186 184 2 (1.07%)
Groote Eylandt ( )n  92 184 184 0
Northern Chinese ( )n  65 130 130 0
Southern Chinese ( )n  93 186 186 0
Chinese Families ( )n  84 168 168 0
Javanese ( )n  68 136 136 0
Melanesian ( )n  139 278 277 1 (.36%)
Micronesian ( )n  106 212 212 0
Polynesian ( )n  169 338 335 3 (.89%)
Nepalese ( )n  116 232 232 0
Total ( )an  941 1,882 1,876 6 (.32%)
a Excludes Chinese-family samples.
Table 2
HLA Haplotypes of Subjects Carrying 845 GrA
POPULATION
HAPLOTYPE OF
HLA-A HLA-B
Cape York Australian Aboriginal 0301a/3401 0702a/1301
3201a/2402 4801a/3503
Melanesian (New Caledonia) 0201/2402 4002/5601
Polynesian (Cook Islands) 3002a/2402 0702a/5502
Polynesian (Western Samoa) 0301a/0206 0702a/4010
Polynesian (Western Samoa) 0301a/2402 )
a Caucasian specific or universal allele.
with ∼1/300 Caucasians expressing the disorder (Ed-
wards et al. 1988; Leggett et al. 1990). It has not been
widely recognized in populations other than Caucasians;
however, it is unclear whether this lack of expression in
other populations is due to dietary differences affecting
clinical expression or is due to differences in gene fre-
quency. The recent identification of HFE has now made
it possible to screen for the 845 GrA and 187 CrG
mutations in HFE, in order to analyze their geographical
distribution. In a recent study, 2,978 subjects from a
variety of ethnic backgrounds were screened for 845
GrA and 187 CrG, and results showed worldwide al-
lele frequencies of 1.9% for 845 GrA and 8.1% for
187 CrG (Merryweather-Clarke et al. 1997).
845 GrA was found to be most prevalent in northern
European populations, with the highest frequency being
seen in 90 Irish chromosomes (allele frequency 10%);
and it was absent from the African, Asian, and Austra-
lasian populations studied. 187 CrG was found to be
present in almost all populations, with the highest fre-
quency in 56 Basque chromosomes (allele frequency
30.4%). Another study (Chang et al. 1997) found that
845 GrA was very rare in a Chinese population, show-
ing a 0.33% carrier rate. Neither of these studies used
any genetic markers to indicate the ancestry of the sam-
ples screened. The present study screened HLA-typed
samples from various non-Caucasian populations, for
both 845 GrA and 187 CrG, to determine the prev-
alence of these mutations in populations in which he-
mochromatosis is rare—and to use this in conjunction
with the distribution of HLA alleles, in order to deter-
mine the likely ancestral origin of 845 GrA and 187
CrG.
Subjects, Material, and Methods
Samples for 845 GrA Analysis
Samples were collected from Australian Aboriginal
Cape York ( ), Australian Aboriginal Groote Ey-n  93
landt ( ), northern Chinese ( ), southernn  92 n  65
Chinese ( ), Chinese family ( ), Javanesen  93 n  84
( ), Melanesian ( ), Micronesian (n  68 n  139 n 
), Polynesian ( ), and Nepalese ( )106 n  169 n  116
subjects ( ). Subjects were unrelated excepttotal  1,025
for 84 subjects from Chinese families. These samples
were screened for 845 GrA by use of PCR and restric-
tion-enzyme digestion, as described below.
Samples for 187 CrG Analysis
Australian Aboriginal Cape York population (n 
), Australian Aboriginal Groote Eylandt population90
( ), northern Chinese ( ), southern Chinesen  101 n  67
( ), and Chinese family ( ) subjects weren  97 n  88
screened for 187 CrG ( ), by use of PCR andtotal  443
restriction-enzyme digestion, as described below. Sub-
jects were unrelated except for 88 subjects from Chinese
families.
DNA Extraction
Genomic DNA was extracted, by means of standard
methods (Sambrook et al. 1989), from whole blood.
PCR Amplification and Restriction-Enzyme Digestion of
HFE Mutations
PCR amplification of the HFE regions containing 845
GrA and 187 CrG was performed as described else-
where (Cullen et al. 1997), by means of oligonucleotide
primers described elsewhere (Feder et al. 1996). The an-
nealing temperatures were 55C, for amplification of the
region containing 845 GrA, and 60C, for amplification
of the region containing 187 CrG. Detection of 845
GrA was by SnaBI digestion, as described elsewhere
(Cullen et al. 1997).
The presence of 187 CrG results in the loss of a re-
striction site for the enzyme DpnII. Samples were di-
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Table 4
HLA Haplotypes of Subjects Carrying 187 CrG
POPULATION
HAPLOTYPE OF
HLA-A HLA-B
Cape York Australian Aboriginala 0201/3101 2705b/5801b
1101/2402 3501b/5601
3303b/3401 5801b/4001
0101b/0301b 0801b/3901b
0301b/1101 0702b/4001
0101b/2402 5701b/4001
0301b/3401 0702b/3901
0101b/0301b 0702b/0801b
Northern Chinese 2301/3001 1302/4403
1101/3001 4001/4006
2601/2402 4002/4402
1101/0207 )/)
Southern Chinese 0201/0203 4001/4001
0206/1101 1527/5502
0201/2901 4001/0705
0207/1101 4006/3901
0203/2402 4001/3802
1101/2402 4001/1301
Family A 0301b/1101 4402b/3901
0301b/3303 4402b/5801
0301b/3303 4402b/5801
Family B 3303b/1101 5801b/1301
3303b/0206 5801b/4601
a Homozygous for 187 CrG.
b Caucasian-specific or universal allele.
Table 3
Results of 187 CrG Analyses
POPULATION
NO. OF CHROMMOSOMES
Total 187C 187G
Australian Aboriginal:
Cape York ( )n  90 180 171 9 (5.0%)
Groote Eylandt ( )n  101 202 202 0
Northern Chinese ( )n  67 134 130 4 (2.99%)
Southern Chinese ( )n  97 194 188 6 (3.09%)
Chinese Families ( )n  88 176 171 5
Totala ( )n  355 710 691 19 (2.68%)
a Excludes Chinese-family samples.
gested with 2 U DpnII (New England Biolabs) for 2 h
at 37C, in a total volume of 20 ml, according to the
manufacturer’s instructions. Restriction-enzyme digests
were analyzed on a 2% agarose gel. Control samples of
known HFE-mutation status were included, to test re-
striction-enzyme activity.
HLA Typing
All samples were typed for HLA-A and HLA-B by
means of sequence-specific–oligonucleotide hybridiza-
tion, as described elsewhere (Gao et al. 1994).
Results
845 GrA Analysis
Results of 845 GrA screening are shown in table 1.
None of the samples analyzed were found to be ho-
mozygous for 845 GrA; however, two Australian Ab-
original (Cape York population) samples, one Melane-
sian sample, and three Polynesian samples were
heterozygous, giving a combined allele frequency of
0.32% in the populations studied. Chinese-family sam-
ples were excluded from frequency calculations.
The HLA haplotypes of 845 GrA heterozygotes are
shown in table 2. HLA typing indicated that five of the
six subjects found to be heterozygous for 845 GrA car-
ried HLA haplotypes common in Caucasians. In partic-
ular, HLA-A3, carried by three of these six subjects, is
the HLA-A allele recognized as significantly associated
with hemochromatosis in Caucasian populations (Simon
et al. 1976).
The Melanesian subject heterozygous for 845 GrA
carries the HLA-A alleles 0201 and 2402, both of which
are common in Melanesian as well as in Caucasian pop-
ulations. HLA-B 4002 is also common in Caucasian
populations, whereas HLA-B 5601 is a typical Mela-
nesian allele. The HLA class II haplotype of this Mel-
anesian subject also contained Caucasian alleles (data
not shown).
187 CrG Analysis
Results of 187 CrG screening are shown in table 3.
In the Cape York Australian Aboriginal population, one
sample was homozygous for 187 CrG, and seven were
heterozygous (allele frequency 5.0%). 187 CrGwas not
present in the Groote Eylandt Australian Aboriginal
population. Fifteen Chinese samples were heterozygous
for 187 CrG, as were four northern Chinese (2.99%)
samples, six southern Chinese (3.09%) samples, and five
samples from Chinese families. This gives an overall al-
lele frequency of 2.68% (when the Chinese subjects be-
longing to families are excluded).
HLA typing of subjects carrying 187 CrG (shown in
table 4) indicated that all Australian Aboriginal subjects
with this mutation also carry HLA haplotypes that are
Caucasian. It is therefore likely that 187 CrG was in-
troduced into the Cape York Australian Aboriginal pop-
ulation by Caucasian admixture.
HLA typing of the Chinese subjects heterozygous for
187 CrG showed that this mutation was present on
chromosomes carrying a wide variety of HLA haplo-
types, several of which are rare in Caucasians, making
it unlikely that this mutation was introduced into the
northern and southern Chinese populations studied. 187
CrG in the Chinese families, however, is associated with
HLA haplotypes common in Caucasians.
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Discussion
The 845 GrA mutation causative in hemochroma-
tosis was found to be present at a very low frequency
in Australian Aboriginal, Melanesian, and Polynesian
populations and to be absent from Chinese, Javanese,
Micronesian, and Nepalese populations. HLA typing in-
dicated that 845 GrA was found in association with
common Caucasian haplotypes, suggesting that this mu-
tation has been introduced into these populations by
Caucasian admixture. These results are consistent with
the observations of Merryweather-Clarke et al. (1997)
and Chang et al. (1997) and support the widely held
view that this mutation arose on a single chromosome
in a Celtic population that spread by migration through-
out northern Europe, the United States, and Australia.
The 187 CrG mutation was found to be present in
two dissimilar non-Caucasian populations—the Cape
York Australian Aboriginal population and the Chinese;
however, HLA typing indicated that the origin of 187
CrG differed in the two populations. 187 CrG in the
Cape York Aboriginal population was always seen in
conjunction with HLA haplotypes common in Cauca-
sians, suggesting that it was introduced by recent ad-
mixture. 187 CrG was not present in the Groote Ey-
landt, the other Australian Aboriginal population
studied.
In the Chinese samples studied, 187 CrG was asso-
ciated with a wide variety of HLA haplotypes, some of
which are rare in Caucasians. The frequency of 187
CrG in Chinese was low compared with that seen in
Caucasians; however, the variation in HLA haplotypes
makes it unlikely that this mutation was introduced into
the Chinese population by Caucasians and suggests that
187 CrG probably predates 845 GrA. 187 CrG is
clearly much more widespread than 845 GrA; however,
the affect of this mutation on the function of HFE re-
mains to be elucidated.
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